OPTIMIZATION OF EXPRESSION, PURIFICATION, AND STABILIZATION CONDITIONS FOR FLG-HA2-4M2E, A RECOMBINANT PROTEIN IN UNIVERSAL INFLUENZA VACCINE

por A. A. Kovaleva, A. A. Shaldzhyan, M. V. Zaitseva, L. A. Stepanova, L. M. Tsybalova
Publicado 2018

IMMUNIZATION WITH UNIVERSAL INFLUENZA VACCINE ENHANCES IMMUNE RESPONSE TO SUBSEQUENT INFECTION

por M. A. Shuklina, L. A. Stepanova, I. G. Vidyaeva, A. V. Korotkov, E. I. Eletskaya, L. M. Tsybalova
Publicado 2018

Features of immune response against influenza infection in animals vaccinated with recombinant cross-protective vaccine

por L. M. Tsybalova, L. A. Stepanova, A. V. Korotkov, M. A. Shuklina, M. V. Zaitseva, V. I. Grishchenko, R. Yu. Kotlyarov
Publicado 2019

Intranasal immunization with a recombinant protein based on the M2e peptide and second subunit of influenza A viral hemagglutinin fragment induces a cross-protective humoral and Tc...

por M. A Shuklina, L. A Stepanova, A. A. Kovaleva, A. V. Korotkov, A. A. Shaldzhyan, M. V. Zaitceva, E. I. Eletskaya, L. M. Tsybalova
Publicado 2020